Mamantia, Rejane .

HRN: 23-58-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/10/2023
09/16/2023
IV
0.11mg/ml (1ml)
Q8hrs
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: